Large gap with delayed quotes
|
Last quote
04/24/2026
-
20:53:26
|
Bid
04/24/2026 -
20:53:26
|
Bid Volume |
Ask
04/24/2026 -
20:53:26
|
Ask Volume |
|---|---|---|---|---|
|
77.89
-0.97
(
-1.23% )
|
77.85
|
100 |
77.89
|
100 |
Analysis date: 21.04.2026
Global Evaluation
Positive
Positive
The stock is classified in the positive zone since 07.04.2026.
Interest
Strong
Strong
Three stars since 14.04.2026.
Earnings Rev Trend
0.10
0.10
Compared to seven weeks ago, the analysts have not significantly revised their earnings per share estimates (changes between +1% and -1% are considered neutral). But the last significant trend is positive since 09.12.2025 at a price of 78.24.
Evaluation
Undervalued
Undervalued
Based on its growth potential and our own criteria, we believe the share price is currently moderately undervalued.
MT Tech Trend
Positive
Positive
The dividend-adjusted forty day technical trend is positive since 07.04.2026.
4wk Rel Perf
-0.34%
-0.34%
The four-week dividend-adjusted performance versus SP500 is .
Sensibility
Middle
Middle
The stock has been on the moderate-sensitivity level since 27.01.2026.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -1.15%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 3.08%.
Mkt Cap in $bn
97.43
97.43
With a market capitalization >$8bn, CVS HEALTH is considered a large-cap stock.
G/PE Ratio
1.62
1.62
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 1.6 often suggests the projected growth is a result of a base effect, meaning the company can often be in a turn around situation. In this case, the estimated PE is a better indicator of a stock's expected growth than the Long Term Growth (LT Growth).
LT P/E
8.23
8.23
The estimated PE is for the year 2028.
LT Growth
9.88%
9.88%
The annualized growth estimate is for the current year to 2028.
Avg. Nb analysts
23
23
Over the last seven weeks, an average of 23 analysts provided earnings per share estimates.
Dividend Yield
3.49%
3.49%
The twelve month estimated dividend yield represents 28.73% of earnings forecasts.
Beta
3
3
For 1% of index variation, the stock varies on average by 0.03%.
Correlation
0.02
0.02
Stock movements are totally independent of index variations.
Value at Risk
9.29
9.29
The value at risk is estimated at USD 9.29. The risk is therefore 12.01%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
02.01.2002
02.01.2002